ExpreS2ion Biotech (Sweden) Price Prediction
| EXPRS2 Stock | SEK 22.00 1.00 4.35% |
Oversold Vs Overbought
51
Oversold | Overbought |
Using ExpreS2ion Biotech hype-based prediction, you can estimate the value of ExpreS2ion Biotech Holding from the perspective of ExpreS2ion Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ExpreS2ion Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying ExpreS2ion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ExpreS2ion Biotech after-hype prediction price | SEK 23.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ExpreS2ion |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ExpreS2ion Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ExpreS2ion Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of ExpreS2ion Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ExpreS2ion Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ExpreS2ion Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ExpreS2ion Biotech Estimiated After-Hype Price Volatility
In the context of predicting ExpreS2ion Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ExpreS2ion Biotech's historical news coverage. ExpreS2ion Biotech's after-hype downside and upside margins for the prediction period are 16.25 and 29.75, respectively. We have considered ExpreS2ion Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ExpreS2ion Biotech is somewhat reliable at this time. Analysis and calculation of next after-hype price of ExpreS2ion Biotech is based on 3 months time horizon.
ExpreS2ion Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ExpreS2ion Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ExpreS2ion Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ExpreS2ion Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 6.75 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
22.00 | 23.00 | 0.00 |
|
ExpreS2ion Biotech Hype Timeline
ExpreS2ion Biotech is currently traded for 22.00on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ExpreS2ion is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.49%. %. The volatility of related hype on ExpreS2ion Biotech is about 0.0%, with the expected price after the next announcement by competition of 22.00. The book value of the company was currently reported as 2.75. The company recorded a loss per share of 1.55. ExpreS2ion Biotech had not issued any dividends in recent years. The entity had 40:1 split on the 21st of October 2024. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out ExpreS2ion Biotech Basic Forecasting Models to cross-verify your projections.ExpreS2ion Biotech Related Hype Analysis
Having access to credible news sources related to ExpreS2ion Biotech's direct competition is more important than ever and may enhance your ability to predict ExpreS2ion Biotech's future price movements. Getting to know how ExpreS2ion Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ExpreS2ion Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BAVA | Bavarian Nordic | 0.00 | 0 per month | 0.00 | (0.04) | 3.52 | (3.49) | 20.95 | |
| BIOPOR | BioPorto | 0.00 | 0 per month | 0.00 | (0.07) | 6.45 | (6.55) | 17.25 | |
| ZAP | Zaptec AS | 0.00 | 0 per month | 4.47 | 0.04 | 5.53 | (4.41) | 28.05 | |
| CBRAIN | cBrain AS | 0.00 | 0 per month | 0.00 | (0.01) | 5.57 | (5.16) | 14.38 |
ExpreS2ion Biotech Additional Predictive Modules
Most predictive techniques to examine ExpreS2ion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ExpreS2ion using various technical indicators. When you analyze ExpreS2ion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ExpreS2ion Biotech Predictive Indicators
The successful prediction of ExpreS2ion Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ExpreS2ion Biotech Holding, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ExpreS2ion Biotech based on analysis of ExpreS2ion Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ExpreS2ion Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ExpreS2ion Biotech's related companies.
Story Coverage note for ExpreS2ion Biotech
The number of cover stories for ExpreS2ion Biotech depends on current market conditions and ExpreS2ion Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ExpreS2ion Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ExpreS2ion Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
ExpreS2ion Biotech Short Properties
ExpreS2ion Biotech's future price predictability will typically decrease when ExpreS2ion Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ExpreS2ion Biotech Holding often depends not only on the future outlook of the potential ExpreS2ion Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ExpreS2ion Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 138.9 M |
Complementary Tools for ExpreS2ion Stock analysis
When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |